The story of Viagra, and its developer copyright, presents a complex case study for investors. Originally a blockbuster drug, producing billions in revenue , its patent expiration created a flood of knock-off medications, significantly eroding its market share . While some firms may seek to capitalize on similar conditions , the current landscape d